Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management

Zhang,Bo; Guo,Yongjian; Wu,Ketong; Shan,Hong

doi:10.3892/mco.2017.1235

Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management

Authors:
- Bo Zhang
- Yongjian Guo
- Ketong Wu
- Hong Shan
View Affiliations

Affiliations: Department of Radiology, The Sixth Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China, Department of Radiology, The Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China
Published online on: May 4, 2017 https://doi.org/10.3892/mco.2017.1235
Pages: 937-943

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Repeat transcatheter arterial chemoembolization (TACE) becomes more challenging for patients with intrahepatic biloma following TACE for hepatocellular carcinoma (HCC).The purpose of this study was to investigate the clinical course, incidence, imaging features and outcome and to explore the reasonable therapy scheme for intrahepatic biloma following TACE for HCC.A total of 4,695 TACE procedures were performed for 1,923 patients with HCC. Twenty patients with intrahepatic biloma following TACE were studied retrospectively. The incidence of intrahepatic biloma was 1.04% in this study. The 20 patients underwent 55 TACE procedures (mean, 2.75). Portal vein invasion was found in half of the patients. Eleven patients developed round solitary or multiple cystic biloma, 6 patients had branched biloma and 3 patients developed both cystic and branched biloma. Percutaneous drainage was applied for 4 patients. One patient underwent partial hepatectomy and one mortality occurred due to progressive biloma and multiple organ failure. Although severe intrahepatic biloma following TACE is rare, the procedure should be performed with caution. Timely and appropriate management, including percutaneous drainage, partial hepatectomy and antibiotic administration should be performed in the case of any signs of infection.

View Figures

View References

1	Lencioni R and Crocetti L: Local-regional treatment of hepatocellular carcinoma. Radiology. 262:43–58. 2012. View Article : Google Scholar : PubMed/NCBI
2	Llovet JM and Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 37:429–442. 2003. View Article : Google Scholar : PubMed/NCBI
3	Xue TC, Xie XY, Zhang L, Yin X, Zhang BH and Ren ZG: Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis. BMC Gastroenterol. 13:602013. View Article : Google Scholar : PubMed/NCBI
4	Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST and Wong J: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 35:1164–1171. 2002. View Article : Google Scholar : PubMed/NCBI
5	Lo GH: The use of transarterial chemoembolization in hepatiocellular carcinoma 2 cm or smaller. Am J Gastroenterol. 110:1962015. View Article : Google Scholar : PubMed/NCBI
6	Chern MC, Chuang VP, Liang CT, Lin ZH and Kuo TM: Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: Safety, efficacy, and prognostic factors. J Vasc Interv Radiol. 25:32–40. 2014. View Article : Google Scholar : PubMed/NCBI
7	Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet. 359:1734–1739. 2002. View Article : Google Scholar : PubMed/NCBI
8	Lewandowski RJ, Mulcahy MF, Kulik LM, Riaz A, Ryu RK, Baker TB, Ibrahim SM, Abecassis MI, Miller FH, Sato KT, et al: Chemoembolization for hepatocellular carcinoma: Comprehensive imaging and survival analysis in a 172-patient cohort. Radiology. 255:955–965. 2010. View Article : Google Scholar : PubMed/NCBI
9	Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka Y, Ashizawa K, Uetani M, Fukuda T, Okimoto T, Okudaira S, Omagari K, et al: Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol. 181:79–87. 2003. View Article : Google Scholar : PubMed/NCBI
10	Iavarone M, Sangiovanni A, Forzenigo LV, Massironi S, Fraquelli M, Aghemo A, Ronchi G, Biondetti P, Roncalli M and Colombo M: Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation. Hepatology. 52:1723–1730. 2010. View Article : Google Scholar : PubMed/NCBI
11	Guiu B, Deschamps F, Aho S, Munck F, Dromain C, Boige V, Malka D, Leboulleux S, Ducreux M, Schlumberger M, et al: Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads. J Hepatol. 56:609–617. 2012. View Article : Google Scholar : PubMed/NCBI
12	Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan Y, Chen Y, Ge N, Ma Z, Wu Z, et al: Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol. 59:407–412. 2006. View Article : Google Scholar : PubMed/NCBI
13	Yu JS, Kim KW, Jeong MG, Lee DH, Park MS and Yoon SW: Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol. 25:270–274. 2002. View Article : Google Scholar : PubMed/NCBI
14	Chung J, Yu JS, Chung JJ, Kim JH and Kim KW: Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: Interpretation of imaging findings. Br J Radiol. 83:71–81. 2010. View Article : Google Scholar : PubMed/NCBI
15	Spina JC, Ulla M, Yeyati EL, Kucharczyk MC, Irusta H, Savluk JL and García-Mónaco R: MDCT findings after hepatic chemoembolization with DC-beads: What the radiologist needs to know. Abdom Imaging. 38:778–784. 2013. View Article : Google Scholar : PubMed/NCBI
16	Demachi H, Matsui O, Kawamori Y, Ueda K and Takashima T: The protective effect of portoarterial shunts after experimental hepatic artery embolization in rats with liver cirrhosis. Cardiovasc Intervent Radiol. 18:97–101. 1995. View Article : Google Scholar : PubMed/NCBI
17	Zipprich A, Loureiro-Silva MR, D'Silva I and Groszmann RJ: The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver. Am J Physiol Gastrointest Liver Physiol. 295:G197–G202. 2008. View Article : Google Scholar : PubMed/NCBI
18	Bhagat N, Reyes DK, Lin M, Kamel I, Pawlik TM, Frangakis C and Geschwind JF: Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: High incidence of biliary injury. Cardiovasc Intervent Radiol. 36:449–459. 2013. View Article : Google Scholar : PubMed/NCBI
19	Chen MJ, Lin CC, Chang WH and Yang FS: Biloma following repeated transcatheter arterial embolization and complicated by intrahepatic duct stones: A case report. World J Gastroenterol. 11:4764–4765. 2005. View Article : Google Scholar : PubMed/NCBI
20	Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS and Kim CY: Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 198:33–40. 1996. View Article : Google Scholar : PubMed/NCBI
21	Naumann M, Bonsall R and Gupta R: Chemoembolization with drug-eluting beads complicated by intrahepatic biloma. Semin Intervent Radiol. 28:212–217. 2011. View Article : Google Scholar : PubMed/NCBI
22	Maruyama T, Mori A, Tatebe H, Sakai K, Isono N, Ohashi N, Inoue H, Takegoshi S and Okuno M: A novel technique for the internal drainage of extrahepatic biloma complicating transarterial embolization of hepatocellular carcinoma. J Gastroenterol. 42:783–786. 2007. View Article : Google Scholar : PubMed/NCBI
23	Akazawa S, Omagari K, Amenomori M, Nishiyama H, Mizuta Y and Kohno S: Bronchobiliary fistula associated with intrahepatic biloma after transcatheter arterial chemoembolization for hepatocellular carcinoma. J Hepatol. 40:1045–1046. 2004. View Article : Google Scholar : PubMed/NCBI
24	Sun Z, Li G, Ai X, Luo B, Wen Y, Zhao Z, Dong S and Guan J: Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol. 79:164–174. 2011. View Article : Google Scholar : PubMed/NCBI
25	Butt AS, Mujtaba G, Anand S and Krishnaiah M: Management of biliopleural fistula after transarterial chemoembolization of a liver lesion. Can J Gastroenterol. 24:281–283. 2010. View Article : Google Scholar : PubMed/NCBI